Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection

BACKGROUND: Dalbavancin is a lipoglycopeptide antibiotic approved for treatment of skin and soft tissue infections, administered as a single or two-dose treatment. The extended half-life, good penetration into bone and synovial fluid, and bactericidal activity against gram-positive bacteria, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Anna, Thunberg, Ulrica, Söderquist, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588017/
https://www.ncbi.nlm.nih.gov/pubmed/37858087
http://dx.doi.org/10.1186/s12879-023-08709-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588017/
https://www.ncbi.nlm.nih.gov/pubmed/37858087
http://dx.doi.org/10.1186/s12879-023-08709-8

Ejemplares similares